9 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 5 Phase 1, 3 Phase 4, 1 Early Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 5 |
| Phase 4 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Omeprazole 40 mg: new trials by email Literature Review of Omeprazole 40 mg trials Research Report on Omeprazole 40 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Omeprazole vs Vonoprazon in Treatment of H Pylori Infection Clarithromycin 500 mg, Amoxicillin 1 g, Omeprazole 40 mg - H Pylori | Phase 4 | Not yet recruiting | Rehman Medical Institute - RMI | 128 | 2025-07-01 | 2025-06-27 |
| The Mechanism Versus PPI Trial Omeprazole 40 MG, Laryngeal Recalibration Therapy, GERD Lifestyle Recommendations - Laryngopharyngeal Reflux, Cough | Phase 4 | Recruiting | University of California, San Diego | 160 | 2025-06-04 | 2025-08-01 |
| Luminal Fructose Kinetics (MARTINI Study) Omeprazole 40 MG - MASLD | Phase 2 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 22 | 2024-07-01 | 2024-08-06 |
| Evaluation of Pharmacokinetic Interaction Between GSK3640254 and Caffeine, Metoprolol, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin in Healthy Adults GSK3640254 200 mg, Caffeine 200 mg, Metoprolol 100 mg - HIV Infections | Phase 1 | Completed | ViiV Healthcare | 20 | 2020-12-16 | 2024-01-05 |
| Evaluating the Effects of Omeprazole on the Pharmacokinetics of XS004 (Dasatinib) Tablets in Healthy Adult Subjects Under Fasting Conditions Dasatinib ASD, Omeprazole 40 MG - Pharmacokinetics, Drug Interactions | Phase 1 | Completed | Xspray Pharma AB | 17 | 2020-11-01 | 2022-06-27 |
| Assessment and Management of Chronic Dyspepsia in Eastern Uganda Clarithromycin 500mg, Amoxicillin 1000 MG, Omeprazole 40 MG - Helicobacter Pylori Infection, Dyspepsia | Early Phase 1 | Completed | Washington University School of Medicine | 376 | 2018-10-01 | 2020-08-25 |
| A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects Omeprazole 40 MG, Famotidine 40 mg, Telotristat ethyl 250 mg - Drug-drug Interaction | Phase 1 | Completed | Lexicon Pharmaceuticals | 32 | 2017-09-21 | 2018-04-25 |
| Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination Cenicriviroc, Omeprazole, Famotidine - Healthy | Phase 1 | Completed | Tobira Therapeutics, Inc. | 48 | 2016-01-31 | 2017-11-24 |
| Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris Omeprazole 40 mg, Luliconazole Cream 1% - Tinea Pedis, Tinea Cruris | Phase 4 | Completed | Bausch & Lomb Incorporated | 20 | 2015-02-03 | 2019-11-27 |
| Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers Omeprazole 40 MG - Gastroduodenal Ulcer, Marginal Ulcer | Completed | Damascus Hospital | 295 | 2012-01-01 | 2018-07-10 | |
| A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects GSK1605786 500 mg, Midazolam 3 mg, Pioglitazone 15 mg - Crohn's Disease | Phase 1 | Completed | GlaxoSmithKline | 24 | 2011-09-19 | 2017-07-25 |
| Argon Plasma Coagulation for Barrett's Esophagus Argon Plasma Coagulation 90W power, Argon Plasma Coagulation 60W power, Omeprazole 120 mg - Barretts Esophagus With Low Grade Dysplasia | Not applicable | Completed | Maria Sklodowska-Curie National Research Institute of Oncology | 71 | 2002-06-04 | 2019-11-19 |
Acquired Immunodeficiency Syndrome (1) · Barrett Esophagus (1) · Cough (1) · Crohn Disease (1) · Dyspepsia (1) · Dysphonia (1) · Gastroesophageal Reflux (1) · HIV Infections (1) · Infections (1) · Laryngopharyngeal Reflux (1) · Peptic Ulcer (1) · Peptic Ulcer Hemorrhage (1) · Tinea Cruris (1) · Tinea Pedis (1)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Bausch & Lomb Incorporated (1) · Damascus Hospital (1) · GlaxoSmithKline (1) · Lexicon Pharmaceuticals (1) · Maria Sklodowska-Curie National Research Institute of Oncology (1) · Rehman Medical Institute - RMI (1) · Tobira Therapeutics, Inc. (1) · University of California, San Diego (1) · ViiV Healthcare (1) · Washington University School of Medicine (1) · Xspray Pharma AB (1)
United States (8) · Netherlands (1) · Pakistan (1) · Syria (1)
Anya Loncaric (1) · Jose B Saenz, MD, PhD (1) · Max Nieuwdorp, prof (1) · Per Andersson, PhD (1) · Rena Yadlapati, MD (1) · Star Seyedkazemi, PharmD (1) · Suman Wason, MD (1)
R01DK139089 (1)